Oct 6, 2025 · Harrow is redefining the standard of care in eyecare with a portfolio of trusted, high-value pharmaceutical solutions that deliver proven safety, efficacy, and affordability.

Harrow, a leading provider of ophthalmic disease management solutions in North America, was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance …

In September 2025, Harrow announced the launch of Harrow Access for All (HAFA), expanding Harrow’s commitment to make it easier and more affordable for patients to access Harrow’s full …

The Investor Relations website contains information about Harrow, Inc.'s business for stockholders, potential investors, and financial analysts.

At Harrow, we’re passionate about making eyecare more innovative, accessible, and affordable for everyone. Whether you're an eyecare professional, a patient, or a current — or future — member of …

Dec 31, 2024 · Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical …

Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes.

Prior to joining Harrow, he was Founder and Chief Executive Officer of LVMA Consulting, advising emerging biotech companies and top 10 global pharmaceutical organizations on commercial …

Mar 31, 2025 · Document Details Form 10-Q Filing Date May 8, 2025 Document Date March 31, 2025 Form Description Quarterly report which provides a continuing view of a company's financial position …

The Investor Relations website contains information about Harrow, Inc.'s business for stockholders, potential investors, and financial analysts.